Vasoconstrictors
 Vasoconstrictors are the drugs that constricts the
  blood vessels and thereby control tissue
  perfusion.
 They are added to LA to oppose the vasodilatory
  action of local anesthetic agent.
Classification of Vasoconstrictors
   Catecholamines
    Epinephrine
    Norepinephrine
    Dopamine
   Noncatecholamines
    Amphetamine
    Methamphetamine
    Phenylephrine
   Direct acting
    Epinephrine
    Norepinephrine
    Dopamine
    Phenylephrine
   Indirect acting
    Tyramine
    Amphetamine
    Methamphetamine
   Mixed acting
    Metaraminol
    ephedrine
   Receptors β1, β2, β3, alpha receptors
    Alpha receptors:- blood vessels
    β 1:- heart and intestine
    β 2:- bronchi, vascular bed, uterus
    β3:- brown and white adipose tissue


   Alpha receptors
    Activation results in vasoconstriction ( blood vessels)
Maximum recommended dose for
adrenaline
 For healthy patients 0.2mg per appointment
 For cardiac patients 0.04mg per appointment
    0.0125mg ---- 1ml
    0.2mg----1/0.125x 0.2 = 16ml
   1:80,000 = 16 ml in healthy patients
    0.0125mg ---- 1ml
    0.04mg------1/0.125x0.04 = 3.2ml
   1:80,000 = 3.2 ml in cardiac patients
Dilution of vasoconstrictors
   1:1000
     1 gm/1000ml
    1000mg/1000ml
    1mg/ml
   1:10,000
    1000mg/10000ml
    0.1mg/ml
   1:80,000
    0.0125mg/ml
   1:200,000mg/ml
    0.005mg/ml
   1:100,000
    0.01mg/ml
Felypressin (Citanest forte)
 Available as a vasoconstrictor in combination with
  prilocaine
 Acts by directly stimulating vascular smooth
  muscle
 Has little effect on heart or on adrenergic nerve
  trasmission
 Actions more pronounced on venous than
  arteriolar microcirculation
Epinephrine                     Norepinephrine
Receptor activity        Powerful stimulant of α and     Stimulates both α and β
                         β receptors                     receptors, but α effect
                         With higher doses α effects     predominates
                         predominates, whereas
                         lower doses primarily
                         produce β receptor activity




Blood Pressure (BP)      Lesser effect                   Greater increase in BP than
                                                         epinephrine

Central Nervous System   Greater effect of stimulation Does not stimulate central
                         of central nervous system in nervous system in
                         large doses                   therapeutic doses

Cardiovascular system    Greater effect of stimulation
                         of CVS

Bronchi                  Dilatation                      Little or no effect
Heart Rate (HR)          Increase in HR is of greater    Increase in HR is of lesser
                         degree                          degree
Various dilutions available in India and MRD (in terms of m) for normal healthy
           adult individuals and medically compromised individuals




       Dilutions              Normal adult healthy      Medically compromised
                                   individuals                individuals
                             (0.2 mg/appointment)       (0.04 mg/appointment)
                                       (ml)                       (ml)




       1:80,000                       16                          3.2


      1:1,00,000                      20                           4


      1:2,00,000                      40                           8
   What determines the potency of LA?
    Lipid solubility
   What determines the duration of action of LA?
    Protein binding e.g. Bupivacaine
   What determines the onset time of LA?
    pKa
   To what components of LA are patients likely to be
    allergic?
    Methylparaben
    Sodium metabisulfite
    Sulfa drugs(Articaine)
    latex
   What type of LA have greater allergic potential?
    Esters
   How are LA metabolized?
    Esters:- plasma by pseudocholinesterase
    Amide:-in liver by microsomal enzymes
   Why is LA often ineffective when injected in
    area on infection
    area of inflammation
   After LA injection anesthetic effect will disappear
    and re-appear in a definite order. What are the
    sensation in increasing order of resistance to
    conduction?
    Pain < Cold < warm < touch < deep pressure
Toxicity
 The term toxicity, or toxic overdose, refers to the
  symptoms manifested as the result of overdosage
  or excessive administration of a drug.
 This complication depends on a sufficient
  concentration of the drug in the blood-stream to
  adversely affect the central nervous system, the
  respiratory system, or the circulatory system.
 The blood level necessary to produce a toxic
  effect may differ for the same drug from individual
  to individual and in the same individual from day to
  day.
Toxic effects on the central
    nervous system
 Although local anesthetics used in dentistry have
  the ability to produce overt signs and symptoms of
  central nervous system stimulation, the effect is
  actually produced by depression of certain
  inhibitory centers.
  Depression of inhibitory areas allows excitatory
  actions to occur unopposed, leading to overt
  manifestation of central nervous system
  stimulation.
 In subtoxic doses(0.05-4 µg/ml of procaine and
  lidocaine), local anesthetics may be shown to
  produce anti-convulsant effects.
 Epileptic patients exhibit hyper-excitable neurons
  at the cortical site from which their seizures
  originate.
 Subtoxic doses of local anesthetics depress
  these      hyper-excitable    neurons,      thereby
  producing an anticonvulsant effect.
Cortical stimulation



Medullary stimulation



Cortical depression



Medullary depression
Increasing blood levels of local anesthetics (in the
    range of 4.0 to 7.0 µg/ml) produce definite clinical
    signs and symptoms by stimulation of cortex.
    Signs of this degree of toxicity on cortical centers
    include
   talkativeness,
   slurred speech,
    apprehension,
    localized muscular twitching
    tremor of the hands and feet.
   ringing in the ears (tinnitus),
    difficulty focusing the eyes
   disorientation
 Medullary stimulation occurs at the dose of 7.5-
  10.0 µg/ml which causes generalised tonic clonic
  seizures by medullary stimulation.
 In excessive medullary stimulation, cardiovascular
  and respiratory parameters increase.
 Usually, respiratory function is totally ineffective
  during the seizure because of tonic and/or
  asynchronous contraction of the muscles of
  respiration.
 Following the medullary stimulation, a period of
  cortical depression occurs.
   This period is characterized by cortical
  depression followed by medullary depression.
 Cortical depression is manifested as
    Unresponsiveness
    unconsciousness
    Stupor
    coma





   Medullary depression results in severe
     depression of cardiovascular function
    respiratory depression
    hypoxia with its subsequent effect on the cardiac
     mechanism.
Syncope
 It refers to a sudden, transient loss of
  consciousness usually secondary to cerebral
  ischemia due to peripheral pooling of blood
  and reduced cardiac output.
 It can be due to;
    Fright and anxiety
    Emotional stress
    Pain of sudden and unexpected nature
    Sight of blood
   Non psychogenic :-
    Hunger or starvation
    Poor physical condition
    Overcrowded places
Syncope
   It is the most frequent complication of associated
    with LA in dental office.
   It is a form of neurogenic shock and is caused by
    cerebral ischemia secondary to the vasodilatation
    with a corresponding drop in blood pressure.
   It is not always associated with loss of
    conciousness.
   It should be treated as early as possible.
   It is characterised by change in patient’s
    appearance, such as pallor.
Management of syncope
 Any procedure that is going on should
  be stopped and the chair should be
  lowered and legs raised (Trendelburg
  position)
 If the patient is conscious, ask for few
  deep breaths.
 Keep a check on pulse, respiration,
  blood pressure
CPR
   Cardiopulmonary     resuscitation (CPR)       is   an
    emergency procedure for people in cardiac arrest or,
    in some circumstances, respiratory arrest.
   CPR is performed both in hospitals and in pre-hospital
    settings.
   CPR involves physical interventions to create
    artificial circulation through rhythmic pressing
    on the patient's chest to manually pump blood
    through the heart, called chest compressions,
    and usually also involves the rescuer exhaling
    into the patient (or using a device to simulate
    this) to ventilate the lungs and pass oxygen in
    to the blood, called artificial respiration
 Tilt the head back and
  listen for breathing.
 If     not      breathing
  normally, pinch nose
  and cover the mouth
  with yours and blow
  until you see the chest
  rise.
 Give 2 breaths.
    Each breath should
  take 1 second
   If the victim is still not
    breathing normally, coughing
    or moving, begin chest
    compressions. Push down
    on the chest 1½ to 2 inches
    30 times. Pump at the rate
    of 100/minute, faster than
    once per second.
CPR (when one person is doing):

Chest cpmpression : artificial respiration

               4    :    1

CPR (when two persons are doing):

Chest cpmpression : artificial respiration

                    15 : 2

Vasoconstrictors

  • 1.
    Vasoconstrictors  Vasoconstrictors arethe drugs that constricts the blood vessels and thereby control tissue perfusion.  They are added to LA to oppose the vasodilatory action of local anesthetic agent.
  • 2.
    Classification of Vasoconstrictors  Catecholamines Epinephrine Norepinephrine Dopamine  Noncatecholamines Amphetamine Methamphetamine Phenylephrine
  • 3.
    Direct acting Epinephrine Norepinephrine Dopamine Phenylephrine  Indirect acting Tyramine Amphetamine Methamphetamine  Mixed acting Metaraminol ephedrine
  • 4.
    Receptors β1, β2, β3, alpha receptors Alpha receptors:- blood vessels β 1:- heart and intestine β 2:- bronchi, vascular bed, uterus β3:- brown and white adipose tissue  Alpha receptors Activation results in vasoconstriction ( blood vessels)
  • 5.
    Maximum recommended dosefor adrenaline  For healthy patients 0.2mg per appointment  For cardiac patients 0.04mg per appointment 0.0125mg ---- 1ml 0.2mg----1/0.125x 0.2 = 16ml  1:80,000 = 16 ml in healthy patients 0.0125mg ---- 1ml 0.04mg------1/0.125x0.04 = 3.2ml  1:80,000 = 3.2 ml in cardiac patients
  • 6.
    Dilution of vasoconstrictors  1:1000  1 gm/1000ml 1000mg/1000ml 1mg/ml  1:10,000 1000mg/10000ml 0.1mg/ml  1:80,000 0.0125mg/ml  1:200,000mg/ml 0.005mg/ml  1:100,000 0.01mg/ml
  • 7.
    Felypressin (Citanest forte) Available as a vasoconstrictor in combination with prilocaine  Acts by directly stimulating vascular smooth muscle  Has little effect on heart or on adrenergic nerve trasmission  Actions more pronounced on venous than arteriolar microcirculation
  • 8.
    Epinephrine Norepinephrine Receptor activity Powerful stimulant of α and Stimulates both α and β β receptors receptors, but α effect With higher doses α effects predominates predominates, whereas lower doses primarily produce β receptor activity Blood Pressure (BP) Lesser effect Greater increase in BP than epinephrine Central Nervous System Greater effect of stimulation Does not stimulate central of central nervous system in nervous system in large doses therapeutic doses Cardiovascular system Greater effect of stimulation of CVS Bronchi Dilatation Little or no effect Heart Rate (HR) Increase in HR is of greater Increase in HR is of lesser degree degree
  • 9.
    Various dilutions availablein India and MRD (in terms of m) for normal healthy adult individuals and medically compromised individuals Dilutions Normal adult healthy Medically compromised individuals individuals (0.2 mg/appointment) (0.04 mg/appointment) (ml) (ml) 1:80,000 16 3.2 1:1,00,000 20 4 1:2,00,000 40 8
  • 10.
    What determines the potency of LA? Lipid solubility  What determines the duration of action of LA? Protein binding e.g. Bupivacaine  What determines the onset time of LA? pKa  To what components of LA are patients likely to be allergic? Methylparaben Sodium metabisulfite Sulfa drugs(Articaine) latex
  • 11.
    What type of LA have greater allergic potential? Esters  How are LA metabolized? Esters:- plasma by pseudocholinesterase Amide:-in liver by microsomal enzymes  Why is LA often ineffective when injected in area on infection area of inflammation  After LA injection anesthetic effect will disappear and re-appear in a definite order. What are the sensation in increasing order of resistance to conduction? Pain < Cold < warm < touch < deep pressure
  • 12.
    Toxicity  The termtoxicity, or toxic overdose, refers to the symptoms manifested as the result of overdosage or excessive administration of a drug.  This complication depends on a sufficient concentration of the drug in the blood-stream to adversely affect the central nervous system, the respiratory system, or the circulatory system.  The blood level necessary to produce a toxic effect may differ for the same drug from individual to individual and in the same individual from day to day.
  • 13.
    Toxic effects onthe central nervous system  Although local anesthetics used in dentistry have the ability to produce overt signs and symptoms of central nervous system stimulation, the effect is actually produced by depression of certain inhibitory centers.  Depression of inhibitory areas allows excitatory actions to occur unopposed, leading to overt manifestation of central nervous system stimulation.
  • 14.
     In subtoxicdoses(0.05-4 µg/ml of procaine and lidocaine), local anesthetics may be shown to produce anti-convulsant effects.  Epileptic patients exhibit hyper-excitable neurons at the cortical site from which their seizures originate.  Subtoxic doses of local anesthetics depress these hyper-excitable neurons, thereby producing an anticonvulsant effect.
  • 15.
  • 16.
    Increasing blood levelsof local anesthetics (in the range of 4.0 to 7.0 µg/ml) produce definite clinical signs and symptoms by stimulation of cortex. Signs of this degree of toxicity on cortical centers include  talkativeness,  slurred speech,  apprehension,  localized muscular twitching  tremor of the hands and feet.  ringing in the ears (tinnitus),  difficulty focusing the eyes  disorientation
  • 17.
     Medullary stimulationoccurs at the dose of 7.5- 10.0 µg/ml which causes generalised tonic clonic seizures by medullary stimulation.  In excessive medullary stimulation, cardiovascular and respiratory parameters increase.  Usually, respiratory function is totally ineffective during the seizure because of tonic and/or asynchronous contraction of the muscles of respiration.
  • 18.
     Following themedullary stimulation, a period of cortical depression occurs.  This period is characterized by cortical depression followed by medullary depression.  Cortical depression is manifested as Unresponsiveness unconsciousness Stupor coma 
  • 19.
    Medullary depression results in severe  depression of cardiovascular function respiratory depression hypoxia with its subsequent effect on the cardiac mechanism.
  • 20.
    Syncope  It refersto a sudden, transient loss of consciousness usually secondary to cerebral ischemia due to peripheral pooling of blood and reduced cardiac output.  It can be due to; Fright and anxiety Emotional stress Pain of sudden and unexpected nature Sight of blood  Non psychogenic :- Hunger or starvation Poor physical condition Overcrowded places
  • 21.
    Syncope  It is the most frequent complication of associated with LA in dental office.  It is a form of neurogenic shock and is caused by cerebral ischemia secondary to the vasodilatation with a corresponding drop in blood pressure.  It is not always associated with loss of conciousness.  It should be treated as early as possible.  It is characterised by change in patient’s appearance, such as pallor.
  • 22.
    Management of syncope Any procedure that is going on should be stopped and the chair should be lowered and legs raised (Trendelburg position)  If the patient is conscious, ask for few deep breaths.  Keep a check on pulse, respiration, blood pressure
  • 24.
    CPR  Cardiopulmonary resuscitation (CPR) is an emergency procedure for people in cardiac arrest or, in some circumstances, respiratory arrest.  CPR is performed both in hospitals and in pre-hospital settings.
  • 25.
    CPR involves physical interventions to create artificial circulation through rhythmic pressing on the patient's chest to manually pump blood through the heart, called chest compressions, and usually also involves the rescuer exhaling into the patient (or using a device to simulate this) to ventilate the lungs and pass oxygen in to the blood, called artificial respiration
  • 26.
     Tilt thehead back and listen for breathing.  If not breathing normally, pinch nose and cover the mouth with yours and blow until you see the chest rise.  Give 2 breaths.  Each breath should take 1 second
  • 27.
    If the victim is still not breathing normally, coughing or moving, begin chest compressions. Push down on the chest 1½ to 2 inches 30 times. Pump at the rate of 100/minute, faster than once per second.
  • 28.
    CPR (when oneperson is doing): Chest cpmpression : artificial respiration 4 : 1 CPR (when two persons are doing): Chest cpmpression : artificial respiration 15 : 2